Rizvi SM

References (9)

Title : Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy - Rizvi_2016_Neurochem.Res_41_1475
Author(s) : Rizvi SM , Shaikh S , Naaz D , Shakil S , Ahmad A , Haneef M , Abuzenadah AM
Ref : Neurochem Res , 41 :1475 , 2016
Abstract :
PubMedSearch : Rizvi_2016_Neurochem.Res_41_1475
PubMedID: 26886763

Title : Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders - Shaikh_2016_Biotechnol.Appl.Biochem_63_145
Author(s) : Shaikh S , Rizvi SM , Shakil S , Riyaz S , Biswas D , Jahan R
Ref : Biotechnol Appl Biochem , 63 :145 , 2016
Abstract :
PubMedSearch : Shaikh_2016_Biotechnol.Appl.Biochem_63_145
PubMedID: 25402624

Title : Prediction of Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study - Shaikh_2016_CNS.Neurol.Disord.Drug.Targets_15_1216
Author(s) : Shaikh S , Rizvi SM , Suhail T , Shakil S , Abuzenadah AM , Anis R , Naaz D , Dallol A , Haneef M , Ahmad A , Choudhary L
Ref : CNS Neurol Disord Drug Targets , 15 :1216 , 2016
Abstract :
PubMedSearch : Shaikh_2016_CNS.Neurol.Disord.Drug.Targets_15_1216
PubMedID: 27697060

Title : A neuroinformatics study to compare inhibition efficiency of three natural ligands (Fawcettimine, Cernuine and Lycodine) against human brain acetylcholinesterase - Shaikh_2015_Network_26_25
Author(s) : Shaikh S , Zainab T , Shakil S , Rizvi SM
Ref : Network , 26 :25 , 2015
Abstract :
PubMedSearch : Shaikh_2015_Network_26_25
PubMedID: 25611730

Title : A neuroinformatics study describing molecular interaction of Cisplatin with acetylcholinesterase: a plausible cause for anticancer drug induced neurotoxicity - Baig_2014_CNS.Neurol.Disord.Drug.Targets_13_265
Author(s) : Baig MH , Rizvi SM , Shakil S , Kamal MA , Khan S
Ref : CNS Neurol Disord Drug Targets , 13 :265 , 2014
Abstract :
PubMedSearch : Baig_2014_CNS.Neurol.Disord.Drug.Targets_13_265
PubMedID: 24059317

Title : Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study - Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447
Author(s) : Rizvi SM , Shakil S , Biswas D , Shaikh S , Bagga P , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :447 , 2014
Abstract :
PubMedSearch : Rizvi_2014_CNS.Neurol.Disord.Drug.Targets_13_447
PubMedID: 24059302

Title : Current acetylcholinesterase-inhibitors: a neuroinformatics perspective - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391
Author(s) : Shaikh S , Verma A , Siddiqui S , Ahmad SS , Rizvi SM , Shakil S , Biswas D , Singh D , Siddiqui MH , Tabrez S , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :391 , 2014
Abstract :
PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391
PubMedID: 24059296

Title : Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach - Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
Author(s) : Alam A , Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Imran M , Haneef M , Abuzenadah AM , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :487 , 2014
Abstract :
PubMedSearch : Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487
PubMedID: 24059299

Title : Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452
Author(s) : Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Tabrez S , Akhtar S , Kamal MA
Ref : CNS Neurol Disord Drug Targets , 13 :452 , 2014
Abstract :
PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452
PubMedID: 24059300